These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 10809428)

  • 21. Early treatment of CMV infections in allogeneic bone marrow transplant recipients with foscarnet or ganciclovir.
    Bacigalupo A; van Lint MT; Tedone E; Moro F; Sanna MA; Longren M; Trespi G; Frassoni F; Occhini D; Gualandi F
    Bone Marrow Transplant; 1994 Jun; 13(6):753-8. PubMed ID: 7920310
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pre-emptive therapy against cytomegalovirus (CMV) disease guided by CMV antigenemia assay after allogeneic hematopoietic stem cell transplantation: a single-center experience in Japan.
    Kanda Y; Mineishi S; Saito T; Seo S; Saito A; Suenaga K; Ohnishi M; Niiya H; Nakai K; Takeuchi T; Kawahigashi N; Shoji N; Ogasawara T; Tanosaki R; Kobayashi Y; Tobinai K; Kami M; Mori S; Suzuki R; Kunitoh H; Takaue Y
    Bone Marrow Transplant; 2001 Feb; 27(4):437-44. PubMed ID: 11313674
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of CMV-DNA in peripheral blood leukocytes of liver transplant patients after ganciclovir treatment.
    Loginov R; Höckerstedt K; Lautenschlager I
    Arch Virol; 2003 Jul; 148(7):1269-74. PubMed ID: 12827460
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Deferred versus prophylactic therapy with gancyclovir for cytomegalovirus in allograft liver transplantation.
    Lianghui G; Shusen Z; Tingbo L; Yan S; Weilling W; Anwei L
    Transplant Proc; 2004 Jun; 36(5):1502-5. PubMed ID: 15251371
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term outcome of cytomegalovirus infection in simultaneous pancreas-kidney transplant recipients without ganciclovir prophylaxis.
    Rayes N; Seehofer D; Kahl A; Kokott S; Pratschke J; Frei U; Neuhaus P
    Transpl Int; 2007 Nov; 20(11):974-81. PubMed ID: 17680782
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monitoring of cytomegalovirus reactivation after allogeneic stem cell transplantation: comparison of an antigenemia assay and quantitative real-time polymerase chain reaction.
    Yakushiji K; Gondo H; Kamezaki K; Shigematsu K; Hayashi S; Kuroiwa M; Taniguchi S; Ohno Y; Takase K; Numata A; Aoki K; Kato K; Nagafuji K; Shimoda K; Okamura T; Kinukawa N; Kasuga N; Sata M; Harada M
    Bone Marrow Transplant; 2002 Apr; 29(7):599-606. PubMed ID: 11979310
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preemptive therapy with intravenous ganciclovir for the prevention of cytomegalovirus disease in lung transplant recipients.
    Monforte V; Román A; Gavaldà J; Bravo C; Gispert P; Pahissa A; Morell F
    Transplant Proc; 2005 Nov; 37(9):4039-42. PubMed ID: 16386621
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Monitoring low cytomegalovirus viremia in transplanted patients by a real-time PCR on plasma.
    Schvoerer E; Henriot S; Zachary P; Freitag R; Fuchs A; Fritsch S; Risch S; Meyer N; Caillard S; Lioure B; Stoll-Keller F
    J Med Virol; 2005 May; 76(1):76-81. PubMed ID: 15778970
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Evaluation of viral load and antigenemia as markers for relapse cytomegalovirus infection in renal transplant recipients].
    Franco A; Serrano R; Gimeno A; de Juan J; Merino E; Jiménez del Cerro L; Olivares J
    Nefrologia; 2007; 27(2):202-8. PubMed ID: 17564566
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Virologic analysis of 1,000 blood samples processed for cytomegalovirus isolation (viremia) and pp65 antigenemia in immunodepressed patients].
    Reina J; Riera M; Bestard X; Villalonga C; Gascó J
    Med Clin (Barc); 1998 Mar; 110(8):281-4. PubMed ID: 9567253
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapeutic implication of quantitative pp65 antigen assay in living renal transplant in a high seroendemic population.
    Minz RW; Minz M; Kashyap R; Heer M; Udgiri N; Joshi K; Sakhuja VK
    Transplant Proc; 2004 Sep; 36(7):2120-1. PubMed ID: 15518768
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quantitation of cytomegalovirus DNA by real-time polymerase chain reaction in peripheral blood specimens of patients with solid organ transplants: comparison with end-point PCR and pp65 antigen test.
    Allice T; Enrietto M; Pittaluga F; Varetto S; Franchello A; Marchiaro G; Ghisetti V
    J Med Virol; 2006 Jul; 78(7):915-22. PubMed ID: 16721848
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New molecular assays to predict occurrence of cytomegalovirus disease in renal transplant recipients.
    Pellegrin I; Garrigue I; Ekouevi D; Couzi L; Merville P; Merel P; Chene G; Schrive MH; Trimoulet P; Lafon ME; Fleury H
    J Infect Dis; 2000 Jul; 182(1):36-42. PubMed ID: 10882579
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Early diagnosis of cytomegalovirus infection and disease in patients following kidney transplantation].
    Cathomas G; Tamm M; Bock A; Gudat F; Thiel G; Reusser P
    Schweiz Med Wochenschr; 1994 Nov; 124(45):2042-5. PubMed ID: 7973539
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early treatment of CMV antigenemia with ganciclovir for prevention of fatal CMV disease in patients receiving marrow from HLA-matched unrelated donors.
    Shimokawa T; Morishima Y; Kitaori K; Kato C; Sao H
    Int J Hematol; 1999 Aug; 70(2):119-26. PubMed ID: 10497851
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of cytomegalovirus antigenemia and culture assays in patients on and off antiviral therapy.
    St George K; Rinaldo CR
    J Med Virol; 1999 Sep; 59(1):91-7. PubMed ID: 10440814
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Monitoring of human Cytomegalovirus infection by antigenemia and viremia in the first 100 days following renal transplantation and relation to antiviral strategies.
    Terlizzi ME; Costa C; Astegiano S; Sidoti F; Vendrame R; Segoloni GP; Bergallo M; Cavallo R
    Minerva Med; 2008 Jun; 99(3):231-9. PubMed ID: 18497721
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Real-time PCR assay compared with antigenemia assay for detecting cytomegalovirus infection in kidney transplant recipients.
    Kim DJ; Kim SJ; Park J; Choi GS; Lee S; Kwon CD; Ki C; Joh J
    Transplant Proc; 2007 Jun; 39(5):1458-60. PubMed ID: 17580161
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effects of preemptive therapy using a very low threshold of pp65 antigenemia to prevent cytomegalovirus disease in kidney transplant recipients: a single-center experience.
    Saracino A; Colucci R; Latorraca A; Muscaridola N; Procida C; Di Noia I; Santospirito VE; Santarsia G
    Transplant Proc; 2013; 45(1):182-4. PubMed ID: 23375295
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of antigenemia assay and semiquantitative polymerase chain reaction test for monitoring active cytomegalovirus infection in allogeneic hematopoietic cell transplant recipients.
    Pajand O; Ziyaeyan M; Mousavi S; Fatolahzadeh B; Hojabri Z; Bahador A; Abdossamadi Z
    Exp Clin Transplant; 2008 Jun; 6(2):149-54. PubMed ID: 18816243
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.